Who we are

A cooperative oncology group that designs and administers cancer clinical trials

The Canadian Cancer Trials Group (CCTG) is a cooperative oncology group that designs and administers clinical trials in cancer therapy, supportive care and prevention across Canada. We support a collaborative network of researchers, physicians, scientists and statisticians internationally recognized for finding the treatments that give people with cancer longer, better quality lives.

Created in 1980, the group has run trials resulting in major, life-saving breakthroughs in breast, colorectal, blood, lung, ovarian, brain and prostate cancer. The network is made of more than 80 member institution, comprising over 2100 Canadian investigators who have facilitated over 500 trials in more than 40 countries.

CCTG’s Central Operations and Statistics Office is located in the Cancer Research Institute at Queen’s University, with in-house faculty researchers that include clinician scientists, researchers in community health and epidemiology, and biostatisticians.

The group is proud to be one of the national programmes of the Canadian Cancer Society (CCS), the only non-American partner of the US National Clinical Trials Network and collaborators with research cooperative groups around the world. These international partnerships are central to the success of their cancer clinical trials and crucial to the advancement of the cancer research agenda in Canada.

Our mission

To develop and conduct clinical trials aimed at improving the treatment and prevention of cancer with the ultimate goal of reducing morbidity and mortality from this disease.

Find out more in this story: CCTG at Queen's plays a central role in the progress of cancer care

https://www.ctg.queensu.ca/cctg_news/2019-new-investigator-clinical-trials-course

2019 New Investigator Clinical Trials Course

Mark your calendars for the next CCTG New Investigator Clinical Trials Course (NICTC) being held August 7th to the 9th at the Donald Gordon Centre in Kingston, Ontario.

More >>
 
Janet Dancey, Director of CCTG

Canadian Cancer Trials Group awarded $25 million in funding to support clinical trials

The Canadian Cancer Trials Group (CCTG) has been awarded more than 19 million USD over six years (approximately $25 million CAD) from the U.S. National Institutes of Health (NIH) and National Cancer Institute (NCI).

More >>
 

Strength in Numbers

Patients facing a cancer diagnosis invariably have many questions, but one tops the list – what is the best treatment? Answering that question is the compelling goal of medical research that is testing new treatments for similarly-diagnosed patients in carefully monitored and controlled ways.

More >>
 

Innovative study advances personalized medicine for prostate cancer patients

A new clinical trial, opening across Canada, is considered a major advancement in precision medicine for prostate cancer and the first of its kind in the world.

More >>